These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 20610561)
1. Modulation of prohormone convertase 1/3 properties using site-directed mutagenesis. Ozawa A; Peinado JR; Lindberg I Endocrinology; 2010 Sep; 151(9):4437-45. PubMed ID: 20610561 [TBL] [Abstract][Full Text] [Related]
2. Cleavage of recombinant proenkephalin and blockade mutants by prohormone convertases 1 and 2: an in vitro specificity study. Peinado JR; Li H; Johanning K; Lindberg I J Neurochem; 2003 Nov; 87(4):868-78. PubMed ID: 14622118 [TBL] [Abstract][Full Text] [Related]
3. Mutations in the catalytic domain of prohormone convertase 2 result in decreased binding to 7B2 and loss of inhibition with 7B2 C-terminal peptide. Apletalina EV; Muller L; Lindberg I J Biol Chem; 2000 May; 275(19):14667-77. PubMed ID: 10799554 [TBL] [Abstract][Full Text] [Related]
4. Evidence that PC2 is the endogenous pro-neurotensin convertase in rMTC 6-23 cells and that PC1- and PC2-transfected PC12 cells differentially process pro-neurotensin. Rovère C; Barbero P; Kitabgi P J Biol Chem; 1996 May; 271(19):11368-75. PubMed ID: 8626691 [TBL] [Abstract][Full Text] [Related]
5. Mutations of the PC2 substrate binding pocket alter enzyme specificity. Kacprzak MM; Than ME; Juliano L; Juliano MA; Bode W; Lindberg I J Biol Chem; 2005 Sep; 280(36):31850-8. PubMed ID: 16002408 [TBL] [Abstract][Full Text] [Related]
6. Distribution and colocalization of cholecystokinin with the prohormone convertase enzymes PC1, PC2, and PC5 in rat brain. Cain BM; Connolly K; Blum A; Vishnuvardhan D; Marchand JE; Beinfeld MC J Comp Neurol; 2003 Dec; 467(3):307-25. PubMed ID: 14608596 [TBL] [Abstract][Full Text] [Related]
7. Enzymatic characterization of immunopurified prohormone convertase 2: potent inhibition by a 7B2 peptide fragment. Lindberg I; van den Hurk WH; Bui C; Batie CJ Biochemistry; 1995 Apr; 34(16):5486-93. PubMed ID: 7727407 [TBL] [Abstract][Full Text] [Related]
8. Functional characterization of ProSAAS: similarities and differences with 7B2. Fortenberry Y; Hwang JR; Apletalina EV; Lindberg I J Biol Chem; 2002 Feb; 277(7):5175-86. PubMed ID: 11719503 [TBL] [Abstract][Full Text] [Related]
9. Comparative biosynthesis, covalent post-translational modifications and efficiency of prosegment cleavage of the prohormone convertases PC1 and PC2: glycosylation, sulphation and identification of the intracellular site of prosegment cleavage of PC1 and PC2. Benjannet S; Rondeau N; Paquet L; Boudreault A; Lazure C; Chrétien M; Seidah NG Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):735-43. PubMed ID: 8397508 [TBL] [Abstract][Full Text] [Related]
10. Biochemical and cell biological properties of the human prohormone convertase 1/3 Ser357Gly mutation: a PC1/3 hypermorph. Blanco EH; Peinado JR; Martín MG; Lindberg I Endocrinology; 2014 Sep; 155(9):3434-47. PubMed ID: 24932808 [TBL] [Abstract][Full Text] [Related]
11. PC1/3, PC2 and PC5/6A are targeted to dense core secretory granules by a common mechanism. Dikeakos JD; Mercure C; Lacombe MJ; Seidah NG; Reudelhuber TL FEBS J; 2007 Aug; 274(16):4094-102. PubMed ID: 17645548 [TBL] [Abstract][Full Text] [Related]
12. Differential regulation of prohormone convertase 1/3, prohormone convertase 2 and phosphorylated cyclic-AMP-response element binding protein by short-term and long-term morphine treatment: implications for understanding the "switch" to opiate addiction. Espinosa VP; Liu Y; Ferrini M; Anghel A; Nie Y; Tripathi PV; Porche R; Jansen E; Stuart RC; Nillni EA; Lutfy K; Friedman TC Neuroscience; 2008 Oct; 156(3):788-99. PubMed ID: 18771713 [TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide mediated regulation of neuroendocrine associated proprotein convertases and neuropeptide precursor processing in the rat spleen. Lansac G; Dong W; Dubois CM; Benlarbi N; Afonso C; Fournier I; Salzet M; Day R J Neuroimmunol; 2006 Feb; 171(1-2):57-71. PubMed ID: 16337011 [TBL] [Abstract][Full Text] [Related]
14. Role of prohormone convertases in pro-neuropeptide Y processing: coexpression and in vitro kinetic investigations. Brakch N; Rist B; Beck-Sickinger AG; Goenaga J; Wittek R; Bürger E; Brunner HR; Grouzmann E Biochemistry; 1997 Dec; 36(51):16309-20. PubMed ID: 9405066 [TBL] [Abstract][Full Text] [Related]
15. Prohormone convertases 1/3 and 2 together orchestrate the site-specific cleavages of progastrin to release gastrin-34 and gastrin-17. Rehfeld JF; Zhu X; Norrbom C; Bundgaard JR; Johnsen AH; Nielsen JE; Vikesaa J; Stein J; Dey A; Steiner DF; Friis-Hansen L Biochem J; 2008 Oct; 415(1):35-43. PubMed ID: 18554181 [TBL] [Abstract][Full Text] [Related]
17. The SAAS granin exhibits structural and functional homology to 7B2 and contains a highly potent hexapeptide inhibitor of PC1. Cameron A; Fortenberry Y; Lindberg I FEBS Lett; 2000 May; 473(2):135-8. PubMed ID: 10812060 [TBL] [Abstract][Full Text] [Related]
18. Tissue distribution and processing of proSAAS by proprotein convertases. Sayah M; Fortenberry Y; Cameron A; Lindberg I J Neurochem; 2001 Mar; 76(6):1833-41. PubMed ID: 11259501 [TBL] [Abstract][Full Text] [Related]
19. 7B2 is a specific intracellular binding protein of the prohormone convertase PC2. Benjannet S; Savaria D; Chrétien M; Seidah NG J Neurochem; 1995 May; 64(5):2303-11. PubMed ID: 7722516 [TBL] [Abstract][Full Text] [Related]
20. Regulation of cell growth and expression of 7B2, PC2, and PC1/3 by TGFbeta 1 and sodium butyrate in a human pituitary cell line (HP75). Kobayashi I; Jin L; Ruebel KH; Bayliss JM; Hidehiro O; Lloyd RV Endocrine; 2003 Dec; 22(3):285-92. PubMed ID: 14709802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]